title: Lenalidomide-associated tumor flare reaction is manageable in patients with chronic lymphocytic leukemia.
authors.forename: Asher A
authors.initials: AA
authors.lastname: Chanan-Khan
authors.forename: Amy
authors.initials: A
authors.lastname: Whitworth
authors.forename: Naveen
authors.initials: N
authors.lastname: Bangia
authors.forename: Carl W
authors.initials: CW
authors.lastname: Porter
authors.forename: Kelvin
authors.initials: K
authors.lastname: Lee
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000077269:Lenalidomide; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*; D015275:Tumor Lysis Syndrome / Q000209:etiology*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D013792:Thalidomide; D000077269:Lenalidomide